Loading...

NMTC NEUROONE MEDICAL TECHNOLOGIES CORP Capital Structure Changes 8-K Filing

NRN

NMTC

NEUROONE MEDICAL TECHNOLOGIES CORP

(NMTC)

2025 8-K

Show Summary

Summary

Financial Statements

Non-Compliance With Listing...

Equity Incentive Plan

Annual Meeting Results

Financial Results

Nasdaq Compliance

Shareholder Update

Nasdaq Compliance

Preliminary Results

Financial Results

Loan Termination

Distribution Agreement

Executive Changes

Financial Results

Bylaws Amendments

Financial Results Announcement

Annual Meeting Results

Financial Results Announcement

Financial Results Announcement

FDA Clearance for OneRFTM A...

Patent Issuance

Appointment of COO

FDA Questions Response

Financial Results Announcement

Underwriting Agreement

Financial Results Announcement

Annual Meeting Results

Regulation FD Disclosure

Financial Results Announcement

Appointment of Transfer Agent

External Links:

On April 4, 2025, NeuroOne Medical Technologies Corp entered into an Underwriting Agreement to sell 16 million shares at $0.50 each, with an option for an additional 2.4 million shares; the offering closed on April 7, 2025, and proceeds will be used for working capital.

AI Assistant

NEUROONE MEDICAL TECHNOLOGIES CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.